↓ Skip to main content

Anxiolytic, hypnotic and sedative medication use in Australia

Overview of attention for article published in Pharmacoepidemiology & Drug Safety, February 2010
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
5 news outlets

Citations

dimensions_citation
73 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Anxiolytic, hypnotic and sedative medication use in Australia
Published in
Pharmacoepidemiology & Drug Safety, February 2010
DOI 10.1002/pds.1899
Pubmed ID
Authors

Samantha A Hollingworth, Dan J Siskind

Abstract

New sedative drugs have been marketed in Australia in the last few years. We examined the trends in the prescribing of subsidised anxiolytic, hypnotic and sedative (AHS) medication use in the Australian population from 2002 to 2007.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Norway 1 2%
Australia 1 2%
Brazil 1 2%
Unknown 53 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 20%
Researcher 9 16%
Student > Ph. D. Student 8 14%
Student > Bachelor 4 7%
Student > Postgraduate 3 5%
Other 7 13%
Unknown 14 25%
Readers by discipline Count As %
Medicine and Dentistry 17 30%
Psychology 5 9%
Agricultural and Biological Sciences 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Neuroscience 2 4%
Other 9 16%
Unknown 16 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 October 2023.
All research outputs
#1,216,510
of 26,017,215 outputs
Outputs from Pharmacoepidemiology & Drug Safety
#74
of 2,204 outputs
Outputs of similar age
#3,921
of 107,118 outputs
Outputs of similar age from Pharmacoepidemiology & Drug Safety
#1
of 10 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,204 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 107,118 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them